BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22054723)

  • 1. Effect of coronary revascularization on serum collagen biomarkers and left ventricular remodeling in patients with acute myocardial infarction.
    Ren HZ; Zhang XS; Wang LX
    Heart Lung; 2012; 41(4):344-9. PubMed ID: 22054723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction.
    Cerisano G; Pucci PD; Sulla A; Tommasi M; Raspanti S; Santoro GM; Antoniucci D
    Am J Cardiol; 2007 Mar; 99(5):651-6. PubMed ID: 17317366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.
    Radovan J; Vaclav P; Petr W; Jan C; Michal A; Richard P; Martina P
    Mol Cell Biochem; 2006 Dec; 293(1-2):71-8. PubMed ID: 16933032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of serum collagen biomakers on the outcome of acute myocardial infarction treated with percutaneous coronary intervention.
    Gao H; Zhang XS; Zhao Q; Ma LL; Wang LX
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):272-6. PubMed ID: 24441293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of primary percutaneous coronary intervention on serum collagen biomarkers following acute myocardial infarction.
    Kong JB; Li QF; Yang CS; Kong DQ; Wang LX
    Acta Cardiol; 2010 Dec; 65(6):661-4. PubMed ID: 21302672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodeling after myocardial infarction.
    Takino T; Nakamura M; Hiramori K
    Cardiology; 1999; 91(2):81-6. PubMed ID: 10449877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices.
    Murakami T; Kusachi S; Murakami M; Sano I; Uesugi T; Hirami R; Kajiyama A; Kondo J; Tsuji T
    Clin Chem; 1998 Dec; 44(12):2453-61. PubMed ID: 9836712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of primary coronary intervention on myocardial collagen metabolism and left ventricle remodeling predicted by collagen metabolism markers.
    Jirmár R; Pelouch V; Widimský P; Capek J; Andel M; Průsa R; Pechová M
    Int Heart J; 2005 Nov; 46(6):949-59. PubMed ID: 16394591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension.
    Cerisano G; Parodi G; Dovellini EV; Migliorini A; Tommasi M; Raspanti S; Buonamici P; Taddeucci E; Valenti R; Antoniucci D
    J Hum Hypertens; 2009 Jan; 23(1):40-7. PubMed ID: 18701924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.
    Uusimaa P; Risteli J; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
    Circulation; 1997 Oct; 96(8):2565-72. PubMed ID: 9355895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Tsutsui T; Matsui T; Fujii M; Matsumoto T; Yamamoto T; Horie H; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2001 Nov; 38(5):1375-82. PubMed ID: 11691511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of spironolactone on left ventricular remodeling in patients with acute myocardial infarction].
    Dong Q; Liu KS; Liu HB; Li SR; Han YP; Zhang LP; Wang Y; Liu G; Wang XP; Xu LF; Li XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):315-9. PubMed ID: 15932659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.
    Eschalier R; Fertin M; Fay R; Bauters C; Zannad F; Pinet F; Rossignol P
    Circ Heart Fail; 2013 Nov; 6(6):1199-205. PubMed ID: 23983248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
    Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction.
    Van de Graaff E; Dutta M; Das P; Shry EA; Frederick PD; Blaney M; Pasta DJ; Steinhubl SR
    Stroke; 2006 Oct; 37(10):2546-51. PubMed ID: 16960095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
    Hayashi M
    J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.